Emvision Medical Devices Ltd has released a press release.
Leadership Transition
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Stage 2 of Clinical Trial Activated
- Product Development Milestones & Grant Funding Achieved
- CEO Half-Year Update
- Clinical Trial Stage 1 Enrolment Completed
- Trial Progressing on Target and ASA Milestone Achieved
Later from EMvision Medical Devices
- $1.75M Manufacturing Grant Payment Received
- Recruitment at Royal Melbourne Hospital Commences
- Clinical Trial Progress & ASA Milestone Achieved
- Latest Imaging and Clinical Trial Insights
- Appendix 4E & Annual Report to 30 June 2023
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices